Company · CIK 0000899923 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
MYRIAD GENETICS INC · MYGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 FForm 4 → | Sep 22, 4:12 pm EDT | Benjamin Richard WheelerChief Financial Officer | 2,555 | $4.01 | $10,246 | 287,193 | — | |
| Sep 16, 2026 AForm 4 → | Sep 17, 4:34 pm EDT | Vishal SikriEVP, Commercial | 257,731 | — | — | 351,224 | — | |
| Sep 3, 2026 FForm 4 → | Sep 8, 4:18 pm EDT | Jennifer Lynne FoxChief Legal Officer | 4,398 | $3.23 | $14,206 | 305,964 | — | |
| Aug 16, 2026 FForm 4 → | Aug 17, 4:26 pm EDT | Benjamin Richard WheelerChief Financial Officer | 8,761 | $3.03 | $26,546 | 289,748 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.